sEEG-guided responsive neurostimulation to treat neocortical epilepsy: A multicenter retrospective study of the efficacy and safety of depth electrode-mediated neuromodulation.
Publication/Presentation Date
11-17-2025
Abstract
OBJECTIVES: Pivotal trials have established the effectiveness of the Responsive Neurostimulation System (RNS® System) in treating focal epilepsy. In clinical trials, depth leads were primarily used to treat mesial temporal seizure onsets while cortical strip leads were used to treat neocortical seizure onsets. Here, we systematically analyze the safety and efficacy of stereoelectroencephalography (sEEG)-guided depth leads to provide responsive stimulation to neocortical gray matter.
METHODS: Patients were stratified as strong responders (>median cohort seizure reduction %), weak responders (>0% and ≤median cohort seizure reduction %), and anti-responders (≤0%) based on percent seizure reduction at 1 year post-implant (1-Y). Pre-operative T1-weighted magnetic resonance imaging and post-operative computed tomography images were merged, and the Euclidean distance between the sEEG epileptic focus (sEEG-EF) and the nearest RNS System depth lead contacts was calculated.
RESULTS: A total of 87 depth leads were implanted in 55 patients across neocortical brain regions. The median reduction in clinical seizures improved from 66.7% at 1-Y to 77.5% at long-term follow-up (LTFU: 2.35 ± 0.95 years), with 10 patients (18.2%) achieving complete seizure freedom. Seven patients (12.7%) experienced six serious adverse events. At 1-Y, shorter Euclidean distance between the sEEG-EF and RNS System depth leads predicted improved seizure outcome in strong responders (β = -0.84, p = 0.008) but not in weak responders (β = 0.21, p = 0.9) or anti-responders (β = -20.34, p = 0.11). At LTFU, there was no significant relationship between Euclidean distance and seizure reduction in strong responders (β = 0.77, p = 0.18), weak responders (β = 2.05, p = 0.54), or anti-responders (β = 0.24, p = 0.99). Exploratory analyses at 1-Y showed nominal associations between older age (ρ = 0.32), longer epilepsy duration (ρ = 0.27), and non-mesial temporal sEEG-EFs and greater seizure reduction; however, none survived Bonferroni correction (adjusted α = 0.0027; all post-correction p > 0.0027), and no associations were observed at LTFU.
SIGNIFICANCE: In this series, neocortical depth leads for RNS therapy had favorable safety and efficacy and proximity to the sEEG-EF drove initial outcomes for strong responders to RNS therapy.
PLAIN LANGUAGE SUMMARY: In this multi-center study, patients with difficult-to-treat seizures received brain-responsive stimulation using a device called responsive neurostimulation (RNS), which delivers small electrical pulses to reduce seizures. We focused on patients treated with electrodes placed in the brain's outer regions (the neocortex) and guided by a mapping procedure called sEEG. On average, patients had their seizures cut by two-thirds after one year and by more than three-quarters with longer follow-up, with about one in five becoming seizure-free. The treatment was safe, and closer electrode placement to the seizure source helped explain early-but not long-term-improvements.
ISSN
2470-9239
Published In/Presented At
Sadeghzadeh, S., Purger, D. A., Bhanot, P., Johnson, N., Barbosa, D. A. N., Huang, Y., Park, J. J., Schonfeld, E., Abikenari, M. A., Jain, B., Aronson, J. P., Drees, C., Fisher, T. L., Gerrard, J., Gray, T. E., Ghatan, S., Hines, K., Jobst, B. C., Karakis, I., Ojemann, S. G., … Parker, J. J. (2025). sEEG-guided responsive neurostimulation to treat neocortical epilepsy: A multicenter retrospective study of the efficacy and safety of depth electrode-mediated neuromodulation. Epilepsia open, 10.1002/epi4.70180. Advance online publication. https://doi.org/10.1002/epi4.70180
Disciplines
Medicine and Health Sciences
PubMedID
41251192
Department(s)
Department of Surgery
Document Type
Article